Literature DB >> 200191

Influence of cyclic nucleotides and a phosphodiesterase inhibitor on in vitro human blood neutrophil chemotaxis.

I Rivkin, J A Neutze.   

Abstract

Cyclic AMP and dibutyryl cyclic AMP as well as several 8-substituted analogs of cyclic AMP inhibited in vitro human blood neutrophil chemotaxis. Cyclic GMP enhanced chemotaxis. 8-substitution on the cyclic GMP nucleus markedly dampened the cyclic GMP effect. SQ 20,009, a potent phosphodiesterase inhibitor when tested alone inhibited chemotaxis; it potentiated the inhibition or enhancement of chemotaxis when combined with cyclic AMP or cyclic GMP, respectively.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200191

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  4 in total

Review 1.  The role of cAMP regulation in controlling inflammation.

Authors:  A R Moore; D A Willoughby
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

2.  Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation.

Authors:  Jason Michaud; Dong-Soon Im; Timothy Hla
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

Review 3.  The Glyoxalase System and Methylglyoxal-Derived Carbonyl Stress in Sepsis: Glycotoxic Aspects of Sepsis Pathophysiology.

Authors:  Thomas Schmoch; Florian Uhle; Benedikt H Siegler; Thomas Fleming; Jakob Morgenstern; Peter P Nawroth; Markus A Weigand; Thorsten Brenner
Journal:  Int J Mol Sci       Date:  2017-03-17       Impact factor: 5.923

4.  Italian cohort of patients affected by inflammatory bowel disease is characterised by variation in glycerophospholipid, free fatty acids and amino acid levels.

Authors:  Antonio Murgia; Christine Hinz; Sonia Liggi; Jùlìa Denes; Zoe Hall; James West; Maria Laura Santoru; Cristina Piras; Cristina Manis; Paolo Usai; Luigi Atzori; Julian L Griffin; Pierluigi Caboni
Journal:  Metabolomics       Date:  2018-10-10       Impact factor: 4.290

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.